{
    "Trade/Device Name(s)": [
        "ABX PENTRA Calcium CP",
        "ABX PENTRA Creatinine CP",
        "ABX PENTRA Phosphorus CP",
        "ABX PENTRA Amylase CP",
        "ABX PENTRA Urine Control L/H"
    ],
    "Submitter Information": "Horiba ABX",
    "510(k) Number": "K070249",
    "Predicate Device Reference 510(k) Number(s)": [
        "K896224",
        "K941837",
        "K883962",
        "K972297",
        "K020817"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CIC",
        "CGX",
        "CEO",
        "JFJ",
        "JJY"
    ],
    "Summary Letter Date": "January 24, 2007",
    "Summary Letter Received Date": "January 26, 2007",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.1145",
        "21CFR862.1225",
        "21CFR862.1580",
        "21CFR862.1070",
        "21CFR862.1660"
    ],
    "Regulation Name(s)": [
        "Calcium test system",
        "Creatinine test system",
        "Phosphorus (inorganic) test system",
        "Amylase test system",
        "Quality control material (assayed)"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Calcium",
        "Creatinine",
        "Phosphorus",
        "Amylase"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma",
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "ABX PENTRA 400 Clinical Chemistry Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Photometric assay",
        "Kinetic method (Jaff\u00e9)",
        "UV method (phosphomolybdate)",
        "Enzymatic photometric assay"
    ],
    "Methodologies": [
        "Photometry",
        "Colorimetry",
        "Enzymatic assay"
    ],
    "Submission Type(s)": [
        "Reagent",
        "Control",
        "Calibrator"
    ],
    "Document Summary": "FDA 510(k) summary for Horiba ABX reagents and controls for measurement of calcium, creatinine, phosphorus, and amylase on ABX PENTRA 400 Clinical Chemistry Analyzer",
    "Indications for Use Summary": "For quantitative in vitro diagnostic determination of calcium, creatinine, phosphorus, and amylase in human serum, plasma, and urine, and for use of urine control in monitoring assay accuracy and precision on the ABX PENTRA 400.",
    "fda_folder": "Clinical Chemistry"
}